Two independent pathways of regulated necrosis mediate ischemia-reperfusion injury

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 29, 2013, Pages 12024-12029

  Linkermann, Andreas ^a   Bräsen, Jan Hinrich ^a,b   Darding, Maurice ^c   Jin, Mi Kyung ^a   Sanz, Ana B ^d   Heller, Jan Ole ^a   De Zen, Federica ^a   Weinlich, Ricardo ^e   Ortiz, Alberto ^d   Walczak, Henning ^c   Weinberg, Joel M ^f   Green, Douglas R ^e   Kunzendorf, Ulrich ^a   Krautwald, Stefan ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b Institute for Diagnostic Histopathology and Cytopathology   (Germany)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^e ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^f UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Apoptosis; Programmed necrosis; RIP1; RIP3

Indexed keywords

CISPLATIN; CYCLOPHILIN D; PROTEIN KINASE; PROTEIN KINASE INHIBITOR; RECEPTOR INTERACTING PROTEIN KINASE 1; RECEPTOR INTERACTING PROTEIN KINASE 3; SANGLIFEHRIN A; UNCLASSIFIED DRUG;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IN VIVO STUDY; KIDNEY ISCHEMIA; KNOCKOUT MOUSE; MITOCHONDRIAL PERMEABILITY; MOUSE; NECROPTOSIS; NECROSIS; NONHUMAN; PRIORITY JOURNAL; RENAL PROTECTION; REPERFUSION INJURY;

APOPTOSIS; PROGRAMMED NECROSIS; RIP1; RIP3;

ANIMALS; APOPTOSIS; CELL LINE; CYCLOPHILINS; DNA PRIMERS; GENOTYPE; KAPLAN-MEIER ESTIMATE; L-LACTATE DEHYDROGENASE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; NECROSIS; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES; REPERFUSION INJURY;

EID: 84880357849     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1305538110     Document Type: Article

References (54)

1. Vandenabeele P, Galluzzi L, Vanden Berghe T, Kroemer G (2010) Molecular mechanisms of necroptosis: An ordered cellular explosion. Nat Rev Mol Cell Biol 11(10): 700-714.
2. Zhang DW, et al. (2009) RIP3, an energy metabolism regulator that switches TNFinduced cell death from apoptosis to necrosis. Science 325(5938):332-336.
3. Bonventre JV, Weinberg JM (2003) Recent advances in the pathophysiology of ischemic acute renal failure. J Am Soc Nephrol 14(8):2199-2210.
4. Eltzschig HK, Eckle T (2011) Ischemia and reperfusion-from mechanism to translation. Nat Med 17(11):1391-1401.
5. Baines CP, et al. (2005) Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 434(7033):658-662.
6. Kroemer G, Galluzzi L, Brenner C (2007) Mitochondrial membrane permeabilization in cell death. Physiol Rev 87(1):99-163.
7. Nakagawa T, et al. (2005) Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature 434(7033): 652-658.
8. Schinzel AC, et al. (2005) Cyclophilin D is a component of mitochondrial permeability transition and mediates neuronal cell death after focal cerebral ischemia. Proc Natl Acad Sci USA 102(34):12005-12010.
9. Piot C, et al. (2008) Effect of cyclosporine on reperfusion injury in acute myocardial infarction. N Engl J Med 359(5):473-481.
10. Degterev A, et al. (2005) Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol 1(2):112-119.
11. Linkermann A, et al. (2012) Rip1 (receptor-interacting protein kinase 1) mediates necroptosis and contributes to renal ischemia/reperfusion injury. Kidney Int 81(8): 751-761.
12. Smith CC, et al. (2007) Necrostatin: A potentially novel cardioprotective agent? Cardiovasc Drugs Ther 21(4):227-233.
13. Kaczmarek A, Vandenabeele P, Krysko DV (2013) Necroptosis: The release of damageassociated molecular patterns and its physiological relevance. Immunity 38(2): 209-223.
14. Linkermann A, De Zen F, Weinberg J, Kunzendorf U, Krautwald S (2012) Programmed necrosis in acute kidney injury. Nephrol Dial Transplant 27(9):3412-3419.
15. Christofferson DE, Yuan J (2010) Necroptosis as an alternative form of programmed cell death. Curr Opin Cell Biol 22(2):263-268.
16. Kaiser WJ, et al. (2011) RIP3 mediates the embryonic lethality of caspase-8-deficient mice. Nature 471(7338):368-372.
17. Oberst A, et al. (2011) Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis. Nature 471(7338):363-367.
18. Cho YS, et al. (2009) Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 137(6): 1112-1123.
19. Galluzzi L, et al. (2011) Molecular definitions of cell death subroutines: Recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ 19(1):107-120.
20. Vandenabeele P, Vanden Berghe T, Festjens N (2006) Caspase inhibitors promote alternative cell death pathways. Sci STKE 2006(358):pe44.
21. Upton JW, Kaiser WJ, Mocarski ES (2008) Cytomegalovirus M45 cell death suppression requires receptor-interacting protein (RIP) homotypic interaction motif (RHIM)-dependent interaction with RIP1. J Biol Chem 283(25):16966-16970.
22. Upton JW, Kaiser WJ, Mocarski ES (2010) Virus inhibition of RIP3-dependent necrosis. Cell Host Microbe 7(4):302-313.
23. Rebsamen M, et al. (2009) DAI/ZBP1 recruits RIP1 and RIP3 through RIP homotypic interaction motifs to activate NF-kappaB. EMBO Rep 10(8):916-922.
24. Sun X, Yin J, Starovasnik MA, Fairbrother WJ, Dixit VM (2002) Identification of a novel homotypic interaction motif required for the phosphorylation of receptor-interacting protein (RIP) by RIP3. J Biol Chem 277(11):9505-9511.
25. Kung G, Konstantinidis K, Kitsis RN (2011) Programmed necrosis, not apoptosis, in the heart. Circ Res 108(8):1017-1036.
26. Degterev A, et al. (2008) Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat Chem Biol 4(5):313-321.
27. Northington FJ, et al. (2011) Necrostatin decreases oxidative damage, inflammation, and injury after neonatal HI. J Cereb Blood Flow Metab 31(1):178-189.
28. Takahashi N, et al. (2012) Necrostatin-1 analogues: Critical issues on the specificity, activity and in vivo use in experimental disease models. Cell Death Dis 3:e437.
29. Vandenabeele P, Grootjans S, Callewaert N, Takahashi N (2013) Necrostatin-1 blocks both RIPK1 and IDO: Consequences for the study of cell death in experimental disease models. Cell Death Differ 20(2):185-187.
30. Dixon SJ, et al. (2012) Ferroptosis: An iron-dependent form of nonapoptotic cell death. Cell 149(5):1060-1072.
31. Bergsbaken T, Fink SL, Cookson BT (2009) Pyroptosis: Host cell death and inflammation. Nat Rev Microbiol 7(2):99-109.
32. Kayagaki N, et al. (2011) Non-canonical inflammasome activation targets caspase-11. Nature 479(7371):117-121.
33. Kourtis N, Nikoletopoulou V, Tavernarakis N (2012) Small heat-shock proteins protect from heat-stroke-Associated neurodegeneration. Nature 490(7419):213-218.
34. Park KM, Kramers C, Vayssier-Taussat M, Chen A, Bonventre JV (2002) Prevention of kidney ischemia/reperfusion-induced functional injury, MAPK and MAPK kinase activation, and inflammation by remote transient ureteral obstruction. J Biol Chem 277(3):2040-2049.
35. Linkermann A, et al. (2011) Renal tubular Fas ligand mediates fratricide in cisplatininduced acute kidney failure. Kidney Int 79(2):169-178.
36. Park JS, Pasupulati R, Feldkamp T, Roeser NF, Weinberg JM (2011) Cyclophilin D and the mitochondrial permeability transition in kidney proximal tubules after hypoxic and ischemic injury. Am J Physiol Renal Physiol 301(1):F134-F150.
37. Kang TB, et al. (2012) Caspase-8 blocks kinase RIPK3-mediated activation of the NLRP3 inflammasome. Immunity 38(1):27-40.
38. Sanz AB, Sanchez-Niño MD, Ortiz A (2011) TWEAK, a multifunctional cytokine in kidney injury. Kidney Int 80(7):708-718.
39. Oberst A, Green DR (2011) It cuts both ways: Reconciling the dual roles of caspase 8 in cell death and survival. Nat Rev Mol Cell Biol 12(11):757-763.
40. Vanden Berghe T, et al. (2013) Determination of apoptotic and necrotic cell death in vitro and in vivo. Methods, 10.1016/j.ymeth.2013.02.011.
41. Duprez L, et al. (2011) RIP kinase-dependent necrosis drives lethal systemic inflammatory response syndrome. Immunity 35(6):908-918.
42. Linkermann A, et al. (2012) Dichotomy between RIP1-And RIP3-mediated necroptosis in tumor necrosis factor α-induced shock. Mol Med 18:577-586.
43. Festjens N, Vanden Berghe T, Cornelis S, Vandenabeele P (2007) RIP1, a kinase on the crossroads of a cell's decision to live or die. Cell Death Differ 14(3):400-410.
44. Gerlach B, et al. (2011) Linear ubiquitination prevents inflammation and regulates immune signalling. Nature 471(7340):591-596.
45. Ko GJ, et al. (2011) Blocking Fas ligand on leukocytes attenuates kidney ischemiareperfusion injury. J Am Soc Nephrol 22(4):732-742.
46. Jouan-Lanhouet S, et al. (2012) TRAIL induces necroptosis involving RIPK1/RIPK3-dependent PARP-1 activation. Cell Death Differ 19(12):2003-2014.
47. Oberst A, Bender C, Green DR (2008) Living with death: The evolution of the mitochondrial pathway of apoptosis in animals. Cell Death Differ 15(7):1139-1146.
48. Salmena L, et al. (2003) Essential role for caspase 8 in T-cell homeostasis and T-cellmediated immunity. Genes Dev 17(7):883-895.
49. Devalaraja-Narashimha K, Padanilam BJ (2009) PARP-1 inhibits glycolysis in ischemic kidneys. J Am Soc Nephrol 20(1):95-103.
50. Sogabe K, Roeser NF, Venkatachalam MA, Weinberg JM (1996) Differential cytoprotection by glycine against oxidant damage to proximal tubule cells. Kidney Int 50(3):845-854.
51. Boya P, Kroemer G (2008) Lysosomal membrane permeabilization in cell death. Oncogene 27(50):6434-6451.
52. Chen GY, Nuñez G (2010) Sterile inflammation: Sensing and reacting to damage. Nat Rev Immunol 10(12):826-837.
53. Hotchkiss RS, Strasser A, McDunn JE, Swanson PE (2009) Cell death. N Engl J Med 361(16):1570-1583.
54. Newton K, Sun X, Dixit VM (2004) Kinase RIP3 is dispensable for normal NF-kappa Bs, signaling by the B-cell and T-cell receptors, tumor necrosis factor receptor 1, and Tolllike receptors 2 and 4. Mol Cell Biol 24(4):1464-1469.